The ROE as of December 2024 (TTM) for Opthea Limited (OPT) is 398.06%

According to Opthea Limited’s latest financial reports and current stock price. The company's current ROE is 398.06%. This represents a change of 24.66% compared to the average of 319.33% of the last 4 quarters.

Opthea Limited (OPT) Historical ROE (quarterly & annually)

How has OPT ROE performed in the past?

The mean historical ROE of Opthea Limited over the last ten years is 226.64%. The current 398.06% ROE has changed 75.64% with respect to the historical average. Over the past ten years (40 quarters), OPT's ROE was at its highest in in the June 2023 quarter at 1.10%. The ROE was at its lowest in in the June 2022 quarter at -166.36%.

Opthea Limited (OPT) ROE by Quarter and Year

Discovering the peaks and valleys of Opthea Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Opthea Limited (OPT) Average ROE

How has OPT ROE performed in the past?

The current ROE of Opthea Limited (OPT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Opthea Limited (OPT) ROE vs. Peers

How is OPT’s ROE compared to its peers?

Opthea Limited’s ROE is greater than Molecular Partners AG (-39.16%), greater than MediciNova, Inc. (-20.70%), greater than Anebulo Pharmaceuticals, Inc. (-184.40%), less than Champions Oncology, Inc. (66.22%), greater than Cyteir Therapeutics, Inc. (-9.44%), greater than Aerovate Therapeutics, Inc. (-90.19%), greater than Adagene Inc. (-50.10%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.95%), greater than Rezolute, Inc. (-69.83%), greater than AN2 Therapeutics, Inc. (-57.63%), less than Inhibrx Biosciences, Inc. (1.45%), greater than Mineralys Therapeutics, Inc. (-55.92%), less than Eliem Therapeutics, Inc. (0%),

Build a custom stock screener for Opthea Limited (OPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Opthea Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Opthea Limited (OPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Opthea Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.